Erasmus Medical Center
Rotterdam, South Holland, 3015 GD, Netherlands
Location status: Recruiting
Location contact
Laura CG de Graaff, MD, PhD
CONTACT
Sabine E Hannema
SUB_INVESTIGATOR
NCT Number: NCT04463316
Introduction Rare complex syndromes Patients with complex genetic syndromes, by definition, have combined medical problems affecting multiple organ systems, and intellectual disability is often part of the syndrome. During childhood, patients with rare genetic syndromes receive multidisciplinary and specialized medical care; they usually receive medical care from 3-4 medical specialists.
Increased life expectancy Although many genetic syndromes used to cause premature death, improvement of medical care has improved life expectancy. More and more patients are now reaching adult age, and the complexity of the syndrome persists into adulthood. However, until recently, multidisciplinary care was not available for adults with rare genetic syndromes. Ideally, active and well-coordinated health management is provided to prevent, detect, and treat comorbidities that are part of the syndrome. However, after transition from pediatric to adult medical care, patients and their parents often report fragmented poor quality care instead of adequate and integrated health management. Therefore, pediatricians express the urgent need for adequate, multidisciplinary adult follow up of their pediatric patients with rare genetic syndromes.
Medical guidelines for adults not exist and the literature on health problems in these adults is scarce. Although there is a clear explanation for the absence of adult guidelines (i.e. the fact that in the past patients with rare genetic syndromes often died before reaching adult age), there is an urgent need for an overview of medical issues at adult age, for 'best practice' and, if possible, for medical guidelines.
The aim of this study is to get an overview of medical needs of adults with rare genetic syndromes, including:
1. comorbidities 2. medical and their impact on quality of life 3. medication use 4. the need for adaption of medication dose according to each syndrome
Methods and Results This is a retrospective file study. Analysis will be performed using SPSS version 23 and R version 3.6.0.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rotterdam, South Holland, 3015 GD, Netherlands
Location status: Recruiting
Laura CG de Graaff, MD, PhD
CONTACT
Sabine E Hannema
SUB_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intevention, retrospective file study: medical history, laboratory values, additional tests, physical and psychological complaints.
Time frame: 1 year
For example: presence of hypertension, diabetes mellitus, hypercholesterolemia, scoliosis, sleep apnea, hypothyroidism, obesity, psychosis etc.
Time frame: 1 year
For example: glucose, hemoglobin, hematocrit, thyroid hormone, TSH, estrogen, testosterone, LH, FSH, LDL-cholesterol, triglycerides, ASAT, ALAT, gamma-GT, etc
Time frame: 1 year
For example: daytime sleepiness, obstipation, back pain, headache, behavioral problems, fatigue, nycturia, blurry vision, depressive symptoms, etc.
Time frame: 1 year
Use of all medication
dr. Laura C. G. de Graaff-Herder
Other
GROWing Up With Rare GENEtic Syndromes ….When Children With Complex Genetic Syndromes Reach Adult Age
Acronym: GROW UR GENES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836300
22q11 Deletion Syndrome, Abnormalities, Multiple
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT02381457
1p36 Deletion Syndrome, 22q11 Deletion Syndrome
San Francisco, California, United States
View Trial DetailsNCT06740162
Abnormalities, Multiple, Aniridia
Fayetteville, Arkansas, United States
View Trial DetailsNCT06573723
Abnormalities, Multiple, Adrenal Gland Diseases
Buenos Aires, Argentina
View Trial Details